[{"Assets_0_Q3_USD":13939300000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":1642600000.0,"NetIncomeLossConverted_1_Q3_USD":669600000.0,"NetIncomeLossConverted_3_Q3_USD":1323800000.0,"StockholdersEquity_0_Q3_USD":10504400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":114200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":114700000.0,"EarningsPerShareBasic_1_Q3_USD":6.12,"EarningsPerShareBasic_3_Q3_USD":12.12,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":109400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":109200000.0,"EarningsPerShareDiluted_1_Q3_USD":5.86,"EarningsPerShareDiluted_3_Q3_USD":11.54,"RevenuesConverted_1_Q3_USD":2048400000.0,"RevenuesConverted_3_Q3_USD":5693900000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS, INC.","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20191105"}]